MedPath

A pilot study of L-carnitine supplement for liver cirrhosis

Not Applicable
Conditions
iver cirrhosis
Registration Number
JPRN-UMIN000009188
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Severe hepatic encephalopathy 2) Refractory pleural effusion or ascites 3) Jaundice 4) Concurrent disease a) Severe renal disease b) Serious hypertension c) Severe heart disease d) Acute myocardial infarction within 6 months prior to inclusion e) Active cancer f) Severe mental disorder g) Severe drug allergy 5) Pregnant and lactating females; females of childbearing age unless using effective contraception 6) Patients who are concluded to be inappropriate to participate in this study by their physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood ammonia levels
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath